glp-1 weight loss drugs news today weight-loss are transforming lives — but what do they really mean for people facing cancer? We brought together perspectives from researchers, clinicians and patients navigating the promise and the tradeoffs Americans turn to risky unregulated
Description
Achieve Sustainable Results With Personalized Care.
Explore changes in HbA1c and body weight over 26 weeks with DURATION-2.
Effectiveness and Impact Significant Weight Loss: Phase 2 studies showed up to roughly 20% average body weight loss at 52 weeks in participants with obesity
A summary of the guidelines for perioperative management of GLP-1 RAs, GIP agonists, & SGLT2 inhibitors in adults.
A state-by-state look at how affordable GLP-1 drugs like Ozempic and Zepbound really are and where cost keeps patients from access.
The FDA has laid out post-marketing safety testing requirements for Lilly's weight-loss pill Foundayo, including clinical trials.
